✦ LIBER ✦

Idelalisib: targeting PI3Kδ in B-cell malignancies

✍ Scribed by Gilbert, Judith A

Book ID: 121712670
Publisher: The Lancet
Year: 2014
Tongue: English
Weight: 215 KB
Volume: 15
Category: Article
ISSN: 1470-2045
DOI: 10.1016/s1470-2045(14)70052-x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PI3Kδ Inhibition Hits a Sensitive Spot i

PI3Kδ Inhibition Hits a Sensitive Spot in B Cell Malignancies

✍ Vanhaesebroeck, Bart; Khwaja, Asim 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 240 KB

PI3Kδ Inhibition by Idelalisib in Patien

PI3Kδ Inhibition by Idelalisib in Patients with Relapsed Indolent Lymphoma

✍ Gopal, Ajay K.; Kahl, Brad S.; de Vos, Sven; Wagner-Johnston, Nina D.; Schuster, 📂 Article 📅 2014 🏛 Massachusetts Medical Society 🌐 English ⚖ 674 KB

Targeting the PI3K/AKT/mTOR Signaling Ax

Targeting the PI3K/AKT/mTOR Signaling Axis in Children with Hematologic Malignancies

✍ Barrett, David; Brown, Valerie I.; Grupp, Stephan A.; Teachey, David T. 📂 Article 📅 2012 🏛 Adis International Limited (now part of Wolters Kl 🌐 English ⚖ 263 KB

A phase 1 study of the PI3K inhibitor id

A phase 1 study of the PI3K inhibitor idelalisib in patients with relapsed/refractory mantle cell lymphoma (MCL)

✍ Kahl, B. S.; Spurgeon, S. E.; Furman, R. R.; Flinn, I. W.; Coutre, S. E.; Brown, 📂 Article 📅 2014 🏛 American Society of Hematology 🌐 English ⚖ 561 KB

Targeting PI3K/AKT/mTOR pathway in non s

Targeting PI3K/AKT/mTOR pathway in non small cell lung cancer

✍ Fumarola, Claudia; Bonelli, Mara A.; Petronini, Pier Giorgio; Alfieri, Roberta R 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 780 KB

Targeting the PI3K/Akt/mTOR Pathway in M

Targeting the PI3K/Akt/mTOR Pathway in Malignancy: Rationale and Clinical Outlook

✍ Cho, Daniel C. 📂 Article 📅 2014 🏛 Springer International Publishing AG 🌐 English ⚖ 269 KB